Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Raquel Buj, Izaskun Mallona, Anna DÃez-Villanueva, VÃctor Barrera, DÃdac Mauricio, Manel Puig-Domingo, Jordi L. Reverter, Xavier Matias-Guiu, Daniel Azuara, Jose L. RamÃrez, Sergio Alonso, Rafael Rosell, Gabriel CapellÃ, Manuel Perucho, Mercedes Robledo, Miguel A. Peinado, Mireia JordÃ
Published Feb 7, 2016 · Vol. 7, No. 9 · pp. 10536-10546
Liye Chen, Xin Zeng, Esther Kleibeuker, Francesca Buffa, Alessandro Barberis, Russell D. Leek, Ioannis Roxanis, Wei Zhang, Andrew Worth, John S. Beech, Adrian L. Harris, Shijie Cai
Published Jan 22, 2016 · Vol. 7, No. 8 · pp. 9353-9367